Logo image of HYL.BR

HYLORIS PHARMACEUTICALS SA (HYL.BR) Stock Analyst Ratings

EBR:HYL - Euronext Brussels - BE0974363955 - Common Stock - Currency: EUR

5.2  +0.08 (+1.56%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to HYL.BR. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 12.99. This target is 149.77% above the current price.
HYL.BR was analyzed by 7 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about HYL.BR.
In the previous month the buy percentage consensus was at a similar level.
HYL.BR was analyzed by 7 analysts. More opinions would make the average more meaningful.
HYL.BR Historical Analyst RatingsHYL.BR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -49 -44 -39 -34 -29 -24 -19 -14 -9 -4 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 5.205.0516.3212.9918.06 - -2.88% 213.85% 149.77% 247.31%
HYL.BR Current Analyst RatingHYL.BR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2023-12-22 KBC SECURITIES Maintains Buy -> Buy